Nathalie Van den Berghe (N Van den Berghe)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 4

Top Topics

Ulcerative Colitis

Ejection Fraction

Patients With Inflammatory Bowel Disease

Top Venues

Clinical pharmacology and therapeutics

Journal of Crohn's & colitis

Journal of immunology (Baltimore, Md. : 1950)

The British journal of dermatology

KU Leuven

KU Leuven (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

KU Leuven Aug 28 2017

Belgium

PhD researcher :: Department of Pharmaceutical and Pharmacological Sciences

Education History

KU Leuven

Belgium

BSC

KU Leuven

Belgium

MSC

Publications

Nathalie Van den Berghe, Bram Verstockt, Ann Gils, João Sabino, Marc Ferrante, Séverine Vermeire, Paul J Declerck, Debby Thomas
Tissue Exposure does not Explain Non-Response in Ulcerative Colitis Patients with Adequate Serum Vedolizumab Concentrations. Journal of Crohn's & colitis 15 (6) (2021)
Jessica Vandenhaute, Anneleen Avau, Jessica Filtjens, Bert Malengier-Devlies, Maya Imbrechts, Nathalie Van den Berghe, Kourosh Ahmadzadeh, Tania Mitera, Louis Boon, Georges Leclerq, Carine Wouters, Patrick Matthys
Regulatory Role for NK Cells in a Mouse Model of Systemic Juvenile Idiopathic Arthritis. Journal of immunology (Baltimore, Md. : 1950) 203 (12) (2019)
Nathalie Van den Berghe, E De Keyser, Rani Soenen, L Meuleman, S Lanssens, Ann Gils, Jo Lydie Wilfried Lambert
Clinical response correlates with 4-week postinjection ustekinumab concentrations in patients with moderate-to-severe psoriasis. The British journal of dermatology 182 (2) (2019)
Nathalie Van den Berghe, Ann Gils, Debby Thomas
Achieving Mucosal Healing in Inflammatory Bowel Diseases: Which Drug Concentrations Need to Be Targeted? Clinical pharmacology and therapeutics 106 (5) (2019)